In prostate cancer, prostate brachytherapy boost improves biochemical failure at 10 years but does not prolong long-term OS compared to EBRT boost.
A leading professor who specialises in the research of prostate cancer has revealed the one thing all men should know and ask ...
Learn the key warning signs of prostate cancer that men often overlook. Early awareness can make all the difference.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results